Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026)

Valneva SE (VALN) posted quarterly Other Accumulated Expenses of $6.2 million for Q1 2026, up 19.69% year-on-year from $5.1 million in Q1 2025, and down 4.89% on a QoQ basis from $6.5 million in Q4 2025.

Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Other Accumulated Expenses for 4 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 19.69% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.2 million (up 19.69% YoY) and the FY2025 annual result came in at $6.5 million, up 10.42% from the prior year.
  • Other Accumulated Expenses slipped to $6.2 million in Q1 2026 per VALN's latest filing, from $6.5 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for VALN reached as high as $10.8 million in Q2 2025 and fell as low as $673668.9 in Q4 2023.
  • A 4-year average of $6.2 million and a median of $6.2 million in 2026 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses soared 770.27% — and 2025, when it advanced 10.42%.
  • Year by year, Other Accumulated Expenses stood at $673668.9 in 2023, then jumped by 770.27% to $5.9 million in 2024, then advanced by 10.42% to $6.5 million in 2025, then retreated by 4.89% to $6.2 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $6.2 million, $6.5 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn
9 Revolution Medicines 37.76 Bn 37.76 Bn -
10 Valneva SE 850.99 Mn 731.20 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.16 Mn
Dec 31, 2025 6.47 Mn
Sep 30, 2025 8.57 Mn
Jun 30, 2025 10.84 Mn
Mar 31, 2025 5.14 Mn
Dec 31, 2024 5.86 Mn
Dec 31, 2023 673,668.93